Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 2,018.50
-18.40 (-0.90%)
Oct 15, 2026, 3:28 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 1.09 trillion as of October 15, 2026. It is the 1,906th most valuable company in the world and the 95th biggest in India. Its market cap has increased by 130.12% in one year.
Market Cap
1.09T
Enterprise Value
1.12T
Revenue
72.70B
Global Rank
Country Rank
#95 India
PE Ratio
99.79
ChartMarket Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 1.09T, an increase of 2,199.04%. That is a compound annual growth rate of 37.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.09T | 82.33% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.46T |
| Zydus Lifesciences | 1.13T |
| Cipla | 1.07T |
| Mankind Pharma | 979.63B |
| Aurobindo Pharma | 969.28B |
| Glenmark Pharmaceuticals | 639.27B |
| Alkem Laboratories | 627.72B |
| Gland Pharma | 509.42B |